ABSTRACT
BACKGROUND: Food allergies are a growing health problem, and the development of therapies that prevent disease onset is limited by the lack of adjuvant-free experimental animal models. We compared allergic sensitization in patients with food allergy or Wiskott-Aldrich syndrome (WAS) and defined whether spontaneous disease in Was-/- mice recapitulates the pathology of a conventional disease model and/or human food allergy. METHODS: Comparative ImmunoCAP ISAC microarray was performed in patients with food allergy or WAS. Spontaneous food allergy in Was-/- mice was compared to an adjuvant-based model in wild-type mice (WT-OVA/alum). Intestinal and systemic anaphylaxis was assessed, and the role of the high-affinity IgE Fc receptor (FcεRI) in allergic sensitization was evaluated using Was-/- Fcer1a-/- mice. RESULTS: Polysensitization to food was detected in both WAS and food-allergic patients which was recapitulated in the Was-/- model. Oral administration of ovalbumin (OVA) in Was-/- mice induced low titers of OVA-specific IgE compared to the WT-OVA/alum model. Irrespectively, 79% of Was-/- mice developed allergic diarrhea following oral OVA challenge. Systemic anaphylaxis occurred in Was-/- mice (95%) with a mortality rate >50%. Spontaneous sensitization and intestinal allergy occurred independent of FcεRI expression on mast cells (MCs) and basophils. CONCLUSIONS: Was-/- mice provide a model of food allergy with the advantage of mimicking polysensitization and low food-antigen IgE titers as observed in humans with clinical food allergy. This model will facilitate studies on aberrant immune responses during spontaneous disease development. Our results imply that therapeutic targeting of the IgE/FcεRI activation cascade will not affect sensitization to food.
Subject(s)
Food Hypersensitivity/etiology , Food Hypersensitivity/metabolism , Mast Cells/immunology , Mast Cells/metabolism , Receptors, IgE/metabolism , Wiskott-Aldrich Syndrome Protein/genetics , Adult , Allergens/immunology , Anaphylaxis , Animals , Disease Models, Animal , Female , Food Hypersensitivity/diagnosis , Gene Expression , Humans , Immunization , Immunoglobulin E/immunology , Male , Mice , Mice, Knockout , Phenotype , Wiskott-Aldrich Syndrome/diagnosis , Wiskott-Aldrich Syndrome/immunology , Young AdultABSTRACT
Antigen-mediated cross-linking of Immunoglobulin E (IgE) bound to mast cells/basophils via FcÉRI, the high affinity IgE Fc-receptor, is a well-known trigger of allergy. In humans, but not mice, dendritic cells (DCs) also express FcÉRI that is constitutively occupied with IgE. In contrast to mast cells/basophils, the consequences of IgE/FcÉRI signals for DC function remain poorly understood. We show that humanized mice that express FcÉRI on DCs carry IgE like non-allergic humans and do not develop spontaneous allergies. Antigen-specific IgE/FcÉRI cross-linking fails to induce maturation or production of inflammatory mediators in human DCs and FcÉRI-humanized DCs. Furthermore, conferring expression of FcÉRI to DCs decreases the severity of food allergy and asthma in disease-relevant models suggesting anti-inflammatory IgE/FcÉRI signals. Consistent with the improved clinical parameters in vivo, antigen-specific IgE/FcÉRI cross-linking on papain or lipopolysaccharide-stimulated DCs inhibits the production of pro-inflammatory cytokines and chemokines. Migration assays confirm that the IgE-dependent decrease in cytokine production results in diminished recruitment of mast cell progenitors; providing a mechanistic explanation for the reduced mast cell-dependent allergic phenotype observed in FcÉRI-humanized mice. Our study demonstrates a novel immune regulatory function of IgE and proposes that DC-intrinsic IgE signals serve as a feedback mechanism to restrain allergic tissue inflammation.
Subject(s)
Asthma/immunology , Dendritic Cells/immunology , Egg Hypersensitivity/immunology , Immunoglobulin E/immunology , Mast Cells/immunology , Receptors, IgE/immunology , Allergens/immunology , Animals , Asthma/genetics , Asthma/pathology , Cell Migration Assays , Cell Movement/drug effects , Cross-Linking Reagents/chemistry , Cytokines/biosynthesis , Cytokines/metabolism , Dendritic Cells/drug effects , Dendritic Cells/pathology , Egg Hypersensitivity/genetics , Egg Hypersensitivity/pathology , Feedback, Physiological , Gene Expression Regulation , Humans , Immunity, Mucosal , Immunoglobulin E/chemistry , Immunoglobulin E/genetics , Lipopolysaccharides/pharmacology , Mast Cells/drug effects , Mast Cells/pathology , Mice , Mice, Transgenic , Ovalbumin/immunology , Papain/pharmacology , Primary Cell Culture , Protein Binding , Receptors, IgE/chemistry , Receptors, IgE/genetics , Signal TransductionABSTRACT
BACKGROUND: Cysteinyl leukotrienes contribute to Th2-type inflammatory immune responses. Their levels in oesophageal tissue, however, do not distinguish patients with eosinophilic oesophagitis (EoE) from controls. OBJECTIVE: We asked whether mRNA levels of leukotriene C4 synthase (LTC4 S), a key regulator of leukotriene production, could serve as a marker for EoE. METHODS: Digital mRNA expression profiling (nCounter(®) Technology) was performed on proximal and distal oesophageal biopsies of 30 paediatric EoE patients and 40 non-EoE controls. Expression data were confirmed with RT-qPCR. LTC4 S mRNA levels were quantified in whole blood samples. Leukotriene E4 was measured in urine. RESULTS: LTC4 S mRNA levels were elevated in proximal (2.6-fold, P < 0.001) and distal (2.9-fold, P < 0.001) oesophageal biopsies from EoE patients. Importantly, increased LTC4 S mRNA transcripts identified a subpopulation of EoE patients (28%). This patient subgroup had higher serum IgE levels (669 U/mL vs. 106 U/mL, P = 0.01), higher mRNA transcript numbers of thymic stromal lymphopoietin (TSLP) (1.6-fold, P = 0.009) and CD4 (1.4-fold, P = 0.04) but lower IL-23 mRNA levels (0.5-fold, P = 0.04). In contrast, elevated levels of IL-23 mRNA were found in oesophageal biopsies of patients with reflux oesophagitis. LTC4 S mRNA transcripts in whole blood and urinary excretion of leukotriene E4 were similar in EoE patient subgroups and non-EoE patients. CONCLUSION & CLINICAL RELEVANCE: Elevated oesophageal expression of LTC4 S mRNA is found in a subgroup of EoE patients, concomitant with higher serum IgE levels and an oesophageal transcriptome indicative of a more-pronounced allergic phenotype. Together with TSLP and IL-23 mRNA levels, oesophageal LTC4 S mRNA may facilitate diagnosis of an EoE subpopulation for personalized therapy.